Serina Therapeutics (SER) Accumulated Expenses (2017 - 2026)
Serina Therapeutics (SER) posted Accumulated Expenses of $1.2 million for Q4 2025, up 5.51% sequentially from $1.1 million in Q3 2025, and down 15.54% YoY from $1.4 million in Q4 2024.
Serina Therapeutics (SER) Accumulated Expenses (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Accumulated Expenses for 9 years, with the latest figure at $1.2 million in Q4 2025.
- Quarterly Accumulated Expenses fell 15.54% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 15.54% YoY) and the FY2025 annual result came in at $1.2 million, down 15.54% from the prior year.
- Accumulated Expenses climbed to $1.2 million in Q4 2025 per SER's latest filing, from $1.1 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $1.4 million in Q4 2024 and troughed at $173000.0 in Q2 2022.
- A 5-year average of $652350.0 and a median of $561000.0 in 2021 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2024: Accumulated Expenses tumbled 72.19% in 2022, then surged 561.73% in 2024.
- Over 5 years, Accumulated Expenses stood at $212000.0 in 2021, then climbed by 28.77% to $273000.0 in 2022, then surged by 113.55% to $583000.0 in 2023, then soared by 145.11% to $1.4 million in 2024, then dropped by 15.54% to $1.2 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $1.2 million, $1.1 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 979,000.00 |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 320,000.00 |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 583,000.00 |
| Sep 30, 2023 | 293,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Mar 31, 2023 | 196,000.00 |
| Dec 31, 2022 | 273,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Mar 31, 2022 | 178,000.00 |
| Dec 31, 2021 | 212,000.00 |
| Sep 30, 2021 | 539,000.00 |
| Jun 30, 2021 | 622,000.00 |